Skip to main content
Anthony Shields, MD, Oncology, Detroit, MI, DMC Detroit Receiving Hospital & University Health Center

AnthonyFShieldsMDPhD

Oncology • Detroit, MI

Gastrointestinal Cancer

Associate Center Director, Karmanos Cancer Institute, Professor of Oncology, Wayne State University

Join to view full profile

Dr. Shields is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shields' full profile

Already have an account?

  • Office

    4100 John R Street, HW04HO
    Karmanos Cancer Institute
    Detroit, MI 48201
    Phone+1 800-527-6266
    Fax+1 313-576-8767
  • Is this information wrong?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1981 - 1984
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1979 - 1981
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyPhD, Biology, 1973 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1979

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1995 - 2027
  • WA State Medical License
    WA State Medical License 1980 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Karmanos Cancer Institute Receives $630,000 CATCH-UP Grant to Recruit Minority and Rural Patients to Clinical Trials
    Karmanos Cancer Institute Receives $630,000 CATCH-UP Grant to Recruit Minority and Rural Patients to Clinical TrialsAugust 25th, 2020
  • OncLive® Presents State of the Science Summit™ on Gastrointestinal Malignancies
    OncLive® Presents State of the Science Summit™ on Gastrointestinal MalignanciesApril 23rd, 2019
  • CMS Denies Coverage for NaF PET Exams Leaving Experts, Imaging Groups Confused
    CMS Denies Coverage for NaF PET Exams Leaving Experts, Imaging Groups ConfusedJune 8th, 2018
  • Join now to see all

Grant Support

  • Imaging Cellular Stress And Treatment Response Using Positron Emission TomographyNational Cancer Institute2010–2012
  • Develpmental TherapeuticsNational Cancer Institute2005–2009
  • Labeled Thymidine -- Development As A PET Imaging AgentNational Cancer Institute2004–2008
  • Labeled Thymidine-Development As A PET Imaging AgentNational Cancer Institute2005–2006
  • Midcareer Investigator AwardNational Cancer Institute1999–2003
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1997–2003
  • Developmental TherapeuticsNational Cancer Institute2001–2002
  • PET Imaging Of Drug Kinetics And PathwaysNational Cancer Institute1999–2002
  • Metabolic Measurement In Lymphoma Treated With ChemotherapyNational Cancer Institute1996–1997
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1988–1994
  • Labeled Thymidine: Development As A PET Imaging AgentNational Cancer Institute1987–1993
  • Labeled Thymidine--Development As A PET Imaging AgentNational Cancer Institute1985–1987

Professional Memberships

Hospital Affiliations

Dr. Anthony Shields, Dr. Anthony Shields, MD, Dr. A Shields, Dr. Anthony F Shields